No Data
No Data
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024
Agios Pharmaceuticals Price Target Announced at $51.00/Share by Scotiabank
Leerink Partners Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating
4 Analysts Have This To Say About Agios Pharmaceuticals
Raymond James Upgrades Agios Pharmaceuticals(AGIO.US) to Buy Rating, Announces Target Price $51
Express News | Raymond James Reinstates Outperform on Agios Pharmaceuticals, Announces $51 Price Target